Trials / Completed
CompletedNCT00677391
Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population
Randomized Trial of Obese Non-Diabetic Malaysians Using Sibutramine: A Randomized Double-Blind Placebo-Controlled Study of Sibutramine in the Management of Obese Subjects in Malaysia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 103 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study was to evaluate the efficacy and the safety of sibutramine vs. placebo in combination with a hypocaloric diet on weight-loss in overweight and obese Malaysian subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sibutramine | Capsules, Wk 0: 10mg, once daily; Wks 4-24: 10mg or 15mg, once daily, dosage escalation based upon investigator's assessment. |
| DRUG | Placebo | Capsules, once daily |
Timeline
- Start date
- 2002-12-01
- Primary completion
- 2004-11-01
- First posted
- 2008-05-14
- Last updated
- 2008-05-14
Source: ClinicalTrials.gov record NCT00677391. Inclusion in this directory is not an endorsement.